There are currently 47 ongoing clinical trials involving Recurrent Medulloblastoma
Of the 47 trials,24 trials are in Phase II
Furthermore, 10 trials are in Phase I
United States of America
Ireland
United States of America
United States of America
Japan
United Kingdom
United States of America
United States of America
Australia
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer